Much heat, little new light in Mylan’s Congressional hearing over EpiPen pricing
Mylan CEO sticks to authorized-generic strategy for price relief
TraceLink touts 100+ customers for global traceability mandates
Sharpens aim at competitor SAP, while enhancing technical specs
Global pharma market will reach $1.12 trillion in 2022
Roche could overtake Novartis as the No. 1 global firm by then, says Evaluate Pharma
Sonoco ThermoSafe enters active temperature-controlled container market
Acquires PharmaPort assets from AAR
Drug pricing brawl turns to PBMs
Pharmacy benefit managers feel some marketplace heat even as they establish new benefit programs
Marken deepens its clinical trial logistics presence in India
Partnership with Jeena & Co., a leading provider
Veeva touts its Events Management solution’s acceptance by Big Pharma
In first year, the product has six of Top 20 companies as clients
Walgreens Boots Alliance continues its consolidation of pharma distribution
Walgreens-Rite Aid merger is still pending
Cold Chain Global Forum is coming up
Largest industry gathering for temperature-controlled logistics and distribution
Systech beefs up its traceability business in India
Serialization and traceability mandates move forward there; anti-counterfeiting is also a focus
CVS Health continues focusing on the value of adherence
New study finds payer cost savings for patients with comorbidities
More analytics horsepower for defining prescriber profiles
Zephyr Health adds Referral and Segment Analytics to its Illuminate data service
When is a branded drug a generic? When it is sold by Mylan…
EpiPen controversy has a new twist: paying lower rebates to state Medicaid programs
Use a tear strip to guard against product tampering
A newly designed label for vials and other containers prevents illicit reuse of pharma containers
Cold chain consolidation: CSafe Global and Kalibox
Acquisition expands CSafe’s manufacturing capacity in Europe
Addressing the aggregation problem in pharma traceability
Xyntek and Antares Vision build a serialization solution
5 CAPA best practices for clinical research
Integrating patient training into product launches
The growing market for self-administered injectables calls for better patient-training resources
Value frameworks are here: What to do about them?
A host of evaluation methodologies are defining ‘value’ in drug prices
Orphan drug commercialization is maturing
Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs
Uncertainty around the pediatric priority review voucher (PRV) program
Advancing the biopharma cold chain
Vendors and service providers scramble to serve a growing market
Using near real-time medical claims to target physicians with newly diagnosed patients
A conversation with Gerry Gleeson, Walgreens Specialty Pharmacy
Since 1841: The Story of an Enduring Family Business
Morris & Dickson publishes a family and company history
Specialty drug market access reality check
Ten payer pressures to act on now
Moving From Big Pharma To A Small Company? You May Be In For A Few Surprises
Sponsored by TGaS Advisors
Mylan will create a generic EpiPen, competing against itself
More unusual gyrations as Mylan attempts to quell uprising against its pricing policies
J.D. Power pharmacy satisfaction survey: independents on top in brick-and-mortar
Good Neighbor and Health Mart franchises trade top positions
Mylan’s EpiPen re-energizes drug pricing disputes
Presidential politicking adds momentum to the growing backlash, and not just for Mylan
